CDDF Annual Report 2021
The CDDF has published its 2021 annual report which highlights the steps the association has taken to further its mission in the year in order to stimulate advancement in cancer drug development and access. To read the report, click the following link: CDDF Annual...
EOTRC Stats Course: Clinical Trial Statistics for Non-Statisticians (14-17 June 2022, Brussels)
EORTC Statistics Course (14-17 June 2022, Brussels) Develop the statistical knowledge required to better understand today’s cancer clinical trials! The EORTC provides an introduction to the statistical methods used for the design, conduct and analysis of cancer...
NEW CDDF BROCHURE
Read the latest version of the CDDF brochure HERE!
European Pharmaceutical Review (Dec, 2021): CDDF Article
The CDDF's article on "United efforts to accelerate drug development" has been published in the European Pharmaceutical Review (Dec, 2021). In the article, Prof. John Smyth (Chairman), Prof. Axel Glasmacher (Treasurer) and Prof. Jaap Verweij (Managing Director)...
Happy Christmas!
The CDDF team wishes you a happy holiday season! Thank you for your continued support and collaboration in 2021.
CDDF’s New Corporate Video
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021
EMA’s human medicines committee (CHMP) recommended two oncology medicines for approval at its October 2021 meeting. To read meeting highlights from CHMP (11-14 October 2021), click here:...
EORTC FREE WEBINAR: “CLINICAL TRIALS: THE PATIENT IN ACADEMIC STUDIES”
EORTC is organizing a free one-hour webinar for the lay audience which will be held on the 15th September, 2021 from 1:30-2.30 pm CEST. The topic will be “Clinical trials – The patient in academic studies” and the challenges patients face in this regard: where to find...
AAADV-CDDF Satellite Session on Global Pediatric Neuro-Oncology Network
The AAADV and the CDDF hold a joint satellite session on Global Pediatric Neuro-Oncology Network at the 2021 AAADV workshop on 29 September 2021. Stay informed about the workshop and join the stimulating discussion with renowned experts in oncology drug development....